Long term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase 2, randomised, double-blind BOLT study British Journal of Dermatology Dummer, R., Guminski, A., Gutzmer, R., Lear, J., Lewis, K., Chang, A. S., Combemale, P., Dirix, L., Kaatz, M., Kudchadkar, R., Loquai, C., Plummer, R., Schulze, H., Stratigos, A., Trefzer, U., Squitteri, N., Migden, M. 2019; Accepted (TBD)